[The relationship of non-Hodgkin's lymphoma with P16 protein expression].
The expression of P16 protein was examined in 45 cases of non-Hodgkin's lymphoma (NHL), 4 cases of reactive hyperplasia of lymph node (RHLN) and 6 cases of normal spleen with immunohistochemical staining. Positive reaction of P16 protein was observed in some lymphocytes of RHLN and splenic nodule and around splenic sinus. The positive rate of P16 protein expression in NHL was 37.8% (17/45). The positive rates of P16 protein expression for the low intermadiate- and high-grade malignancy groups were 66.7% (10/15), 37.5% (6/16) and 7.1% (1/14) respectively. There was a significant difference between the low malignancy NHL and the high malignancy NHL (P < 0.005) in expression rate of P16 protein. It suggests that P16 protein expression may be one of the important parameters in estimating the prognosis of patients with NHL.
Zhang
S
S
Department of Pathology, First Affiliated Hospital, Chengdu.
Li
F
F
Shi
Y
Y
Li
G
G
Du
B
B
Liu
H
H
Liu
W
W
Chen
L
L
Rong
X
X
Zhang
X
X
Yang
G
G
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D008228:Lymphoma, Non-Hodgkin / Q000378:metabolism*; D008875:Middle Aged; D047428:Protein Kinase Inhibitors
D019941:Cyclin-Dependent Kinase Inhibitor p16; D047428:Protein Kinase Inhibitors